Clinical Trials in Chelyabinsk, Russia
Locations / Chelyabinsk, Russia
Delta Trials records 719 clinical trials conducted in Chelyabinsk, Russia, making it a notable site of clinical research activity. These trials across 527 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 75 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Chelyabinsk has changed over time.
719
Total Trials
527
Conditions
75
Terminated since 2020
Browse by condition (527 total)
- Asthma 33 trialsAll Asthma trials
- Non-small cell lung cancer 29 trialsAll Non-small cell lung cancer trials
- Diabetes mellitus, type 2 23 trialsAll Diabetes mellitus, type 2 trials
- Breast cancer 19 trialsAll Breast cancer trials
- Pulmonary disease, chronic obstructive 16 trialsAll Pulmonary disease, chronic obstructive trials
- Rheumatoid arthritis 11 trialsAll Rheumatoid arthritis trials
- Melanoma 11 trialsAll Melanoma trials
- Chronic obstructive pulmonary disease 10 trialsAll Chronic obstructive pulmonary disease trials
- Atrial fibrillation 10 trialsAll Atrial fibrillation trials
- Metastatic breast cancer 9 trialsAll Metastatic breast cancer trials
- Psoriatic arthritis 8 trialsAll Psoriatic arthritis trials
- Systemic lupus erythematosus 7 trialsAll Systemic lupus erythematosus trials
- Schizophrenia 7 trialsAll Schizophrenia trials
- Ovarian cancer 7 trialsAll Ovarian cancer trials
- Atopic dermatitis 7 trialsAll Atopic dermatitis trials
- Arthritis, psoriatic 6 trialsAll Arthritis, psoriatic trials
- Carcinoma, non-small-cell lung 6 trialsAll Carcinoma, non-small-cell lung trials
- Chronic kidney disease 6 trialsAll Chronic kidney disease trials
- Diabetes 6 trialsAll Diabetes trials
- Thromboembolism 6 trialsAll Thromboembolism trials